Radiation therapy versus radical prostatectomy in the PSA era: A urologist's view
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 8 (2) , 87-94
- https://doi.org/10.1016/s1053-4296(98)80004-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level ≤ 10 ng/ml: Radiation therapy or surgery?International Journal of Radiation Oncology*Biology*Physics, 1997
- Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancerUrology, 1996
- Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcomeUrology, 1995
- To the EditorJournal of Urology, 1994
- Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation TherapyJournal of Urology, 1994
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of PatientsJournal of Urology, 1993
- Editorial: Prostate CancerJournal of Urology, 1993
- More on the uro-oncology research group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Radical Surgery Versus Radiotherapy for Adenocarcinoma of the ProstateJournal of Urology, 1982